{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:08:09Z","timestamp":1787170089168,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"am","delay-in-days":269,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.suronc.2020.08.012","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:20:53Z","timestamp":1597926053000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Systematic review of patient reported outcomes (PROs) and quality of life measures after pressurized intraperitoneal aerosol chemotherapy (PIPAC)"],"prefix":"10.1016","volume":"35","author":[{"given":"Abdelkader","family":"Taibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Geyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Mathonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Usseglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvaine","family":"Durand Fontanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.suronc.2020.08.012_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2020.08.012_bib2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.dld.2019.05.035","article-title":"Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)","volume":"51","author":"Phelip","year":"2019","journal-title":"Dig. Liver Dis."},{"issue":"479","key":"10.1016\/j.suronc.2020.08.012_bib3","first-page":"1325","article-title":"[PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis]","volume":"11","author":"H\u00fcbner","year":"2015","journal-title":"Rev. Med. Suisse"},{"issue":"7","key":"10.1016\/j.suronc.2020.08.012_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2020.08.012_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","article-title":"High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis","volume":"244","author":"Esquis","year":"2006","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.012_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2019.08.016","article-title":"Current state of quality of life and patient-reported outcomes research","volume":"121","author":"Bottomley","year":"2019","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.suronc.2020.08.012_bib7","doi-asserted-by":"crossref","first-page":"f167","DOI":"10.1136\/bmj.f167","article-title":"Patient reported outcome measures could help transform healthcare","volume":"346","author":"Black","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.suronc.2020.08.012_bib8","first-page":"675","article-title":"Patient-reported outcome measures: how and why they are collected","volume":"68","author":"Makhni","year":"2019","journal-title":"Instr. Course Lect."},{"issue":"2","key":"10.1016\/j.suronc.2020.08.012_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.suronc.2020.08.012_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2020.08.012_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bulcan.2018.02.008","article-title":"[The role and use of Patient Reported Outcomes in the management of cancer patients]","volume":"105","author":"Marino","year":"2018","journal-title":"Bull. Cancer"},{"issue":"2","key":"10.1016\/j.suronc.2020.08.012_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.suronc.2020.08.012_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gore.2014.10.001","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: a case report","volume":"10","author":"Tempfer","year":"2014","journal-title":"Gynecol Oncol Rep"},{"issue":"12","key":"10.1016\/j.suronc.2020.08.012_bib15","first-page":"6723","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study","volume":"35","author":"Tempfer","year":"2015","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.suronc.2020.08.012_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","article-title":"Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"34","author":"Graversen","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.suronc.2020.08.012_bib17","first-page":"2309","article-title":"Low-dose pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an alternative therapy for ovarian cancer in an octogenarian patient","volume":"35","author":"Giger-Pabst","year":"2015","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.suronc.2020.08.012_bib18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)","volume":"41","author":"Odendahl","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.012_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","volume":"14","author":"Robella","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.012_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919846402","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study","volume":"11","author":"Struller","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.suronc.2020.08.012_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4596176","article-title":"Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: a retrospective cohort study","volume":"2017","author":"Teixeira Farinha","year":"2017","journal-title":"Gastroenterology Research and Practice"},{"issue":"4","key":"10.1016\/j.suronc.2020.08.012_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study","volume":"18","author":"Gockel","year":"2018","journal-title":"J Gastric Cancer"},{"issue":"6","key":"10.1016\/j.suronc.2020.08.012_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"issue":"12","key":"10.1016\/j.suronc.2020.08.012_bib24","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdy449","article-title":"Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016","volume":"29","author":"Marandino","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2020.08.012_bib25","first-page":"283","article-title":"Physical and mental health among cancer survivors: considerations for long-term care and quality of life","volume":"75","author":"Naughton","year":"2014","journal-title":"N. C. Med. J."},{"issue":"7","key":"10.1016\/j.suronc.2020.08.012_bib26","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2020.08.012_bib27","doi-asserted-by":"crossref","first-page":"20180120","DOI":"10.1515\/pp-2018-0120","volume":"3","author":"Dumont","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"6","key":"10.1016\/j.suronc.2020.08.012_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/bjs.10521","article-title":"Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis","volume":"104","author":"Grass","year":"2017","journal-title":"Br. J. Surg."},{"issue":"8","key":"10.1016\/j.suronc.2020.08.012_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US national cancer institute's patient-reported outcomes version of the Common Terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.suronc.2020.08.012_bib30","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s00464-015-4415-3","article-title":"Assessment of patient-reported outcome measures in the surgical treatment of patients with gastric cancer","volume":"30","author":"Straatman","year":"2016","journal-title":"Surg. Endosc."},{"issue":"7","key":"10.1016\/j.suronc.2020.08.012_bib31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/dote.12405","article-title":"Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer","volume":"29","author":"Straatman","year":"2016","journal-title":"Dis. Esophagus"},{"issue":"8","key":"10.1016\/j.suronc.2020.08.012_bib32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1586\/14737140.2014.911090","article-title":"Patient-reported outcomes after neoadjuvant therapy for rectal cancer: a systematic review","volume":"14","author":"Gavaruzzi","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.suronc.2020.08.012_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002633","article-title":"Core set of patient-reported outcomes in pancreatic cancer (COPRAC): an international Delphi study among patients and health care providers","volume":"270","author":"van Rijssen","year":"2019","journal-title":"Ann. Surg."},{"issue":"14","key":"10.1016\/j.suronc.2020.08.012_bib34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","article-title":"What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials","volume":"32","author":"Kotronoulas","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2020.08.012_bib35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.suronc.2020.08.012_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx029","article-title":"Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients","volume":"109","author":"Denis","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.suronc.2020.08.012_bib37","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/bjs.9620","article-title":"Patient-reported outcomes in long-term survivors of metastatic colorectal cancer needing liver resection","volume":"101","author":"Rees","year":"2014","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2020.08.012_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13014-017-0818-8","article-title":"Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer","volume":"12","author":"Mutsaers","year":"2017","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2020.08.012_bib39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamaoncol.2017.0417","article-title":"An international collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer","volume":"3","author":"Zerillo","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.suronc.2020.08.012_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/his.14092","article-title":"Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis","author":"Benzerdjeb","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.suronc.2020.08.012_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdl386","article-title":"Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery","volume":"18","author":"Rubbia-Brandt","year":"2007","journal-title":"Ann. Oncol."},{"issue":"33","key":"10.1016\/j.suronc.2020.08.012_bib42","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2020.08.012_bib43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejso.2019.09.008","article-title":"Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: a mouse model study","volume":"46","author":"Taibi","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.012_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.suronc.2020.02.014","article-title":"Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG","volume":"33","author":"Taibi","year":"2020","journal-title":"Surg Oncol"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740420303625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740420303625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:17:55Z","timestamp":1760757475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740420303625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":43,"alternative-id":["S0960740420303625"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2020.08.012","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of patient reported outcomes (PROs) and quality of life measures after pressurized intraperitoneal aerosol chemotherapy (PIPAC)","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2020.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}